Research Topics
| A MaiselSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordingsEmily Lubien
Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, and University of California, San Diego, USA
Circulation 105:595-601. 2002..In patients with normal systolic function, elevated BNP levels and diastolic filling abnormalities might help to reinforce the diagnosis diastolic dysfunction...
Short-term serial sampling of natriuretic peptides in patients presenting with chest painGene Kwan
Division of Cardiology, Department of Medicine, Veterans Affairs Healthcare System San Diego and University of California, San Diego, California 92161, USA
J Am Coll Cardiol 49:1186-92. 2007..The purpose of this study was to characterize the diagnostic and prognostic utility of short-term dynamic changes in natriuretic peptides in patients presenting with chest pain...
Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implicationsDimitrios Farmakis
Second Department of Cardiology, Athens University Medical School, Attikon University Hospital, Athens, Greece
Congest Heart Fail 14:25-9. 2008..In conclusion, natriuretic peptide values may improve risk stratification in ACS when used in addition to troponin levels and other prognostic markers, but more data are needed to define their role in ACS therapy...
Primary Results of the HABIT Trial (Heart Failure Assessment With BNP in the Home)Alan Maisel
Veterans Affairs Medical Center, San Diego, California Department of Medicine, University of California San Diego, San Diego, California Electronic address
J Am Coll Cardiol 61:1726-35. 2013....
Review on natriuretic peptides: where we are, where we are goingKevin Jiang
VA San Diego Medical Center and the University of California, Division of Cardiology, Department of Medicine, VAMC, 3350 La Jolla Village Dr, San Diego, CA 92161, USA 1 858 552 8585 1 858 552 7490
Expert Opin Med Diagn 2:1137-53. 2008..However, natriuretic peptides should be used as an adjunct test as many circumstances can also influence changes in natriuretic peptide levels...
Post-acute care: the role of natriuretic peptidesAlan Maisel
San Diego VA Medical Hospital and University of California San Diego, CA 92161, USA
Congest Heart Fail 18:S14-6. 2012....
Biomarkers in acute heart failure--state of the artAlan S Maisel
Department of Medicine, Division of Cardiology, San Diego Veterans Affairs Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
Nat Rev Cardiol 9:478-90. 2012..In this Review, we will provide an update on biomarkers considered state of the art in the diagnosis and management of patients with acute HF...
In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED StudySalvatore Di Somma
Emergency Medicine Department, II Medical School University La Sapienza, Sant Andrea Hospital, Via di Grottarossa, 1039 Roma 00189, Italy
Crit Care 14:R116. 2010....
State of the art: using natriuretic peptide levels in clinical practiceAlan Maisel
VA San Diego Healthcare System Cardiology, San Diego, CA 92161, USA
Eur J Heart Fail 10:824-39. 2008..9) NP levels can accelerate accurate diagnosis of heart failure presenting in primary care. 10) NP levels may be helpful to screen for asymptomatic left ventricular dysfunction in high-risk patients...
The diagnosis of acute congestive heart failure: role of BNP measurementsAlan S Maisel
Division of Cardiology and Department of Medicine, San Diego VA Healthcare System, CA 921161, USA
Heart Fail Rev 8:327-34. 2003..Finally, it is possible that use of BNP levels might not only be helpful in assessing whether or not a dyspneic patient has heart failure, but it my turn out to be useful in making both triage and management decisions...
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel
VA San Diego Healthcare System, San Diego, California 92161, USA
J Am Coll Cardiol 55:2062-76. 2010....
Cardiac biomarkers: a contemporary status reportAlan S Maisel
Department of Medicine, Veterans Affairs San Diego Healthcare System and University of California, San Diego, CA 92161, USA
Nat Clin Pract Cardiovasc Med 3:24-34. 2006..At the end of this review we highlight some of the biomarker-guided approaches and strategies that might lead to better and more-effective care of patients...
B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failureVikas Bhalla
Division of Cardiology and General Internal Medicine, and the Department of Medicine and Nursing, Veterans Affairs Medical Center, and the University of California, San Diego, CA 92161, USA
Congest Heart Fail 10:3-27. 2004..This article reviews the literature concerning the use of these peptides in a variety of clinical scenarios and the use of recombinant B-type natriuretic peptide in decompensated heart failure...
Cardiovascular and renal surrogate markers in the clinical management of hypertensionAlan S Maisel
Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA
Cardiovasc Drugs Ther 23:317-26. 2009..Surrogate markers are increasingly employed as predictive endpoints for treatment...
Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational studyAlan S Maisel
University of California, San Diego, Veteran s Affairs Medical Center, San Diego, Calif 92161, USA
Am Heart J 147:1078-84. 2004..B-type natriuretic peptide (BNP) is secreted from the cardiac ventricles in response to increased wall tension...
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breathAlan Maisel
University of California San Diego, Veterans Affairs Medical Center, San Diego, California 92161, USA
J Am Coll Cardiol 44:1328-33. 2004....
Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysisAlan S Maisel
Veterans Administration, San Diego, California 92161, USA
J Am Coll Cardiol 52:534-40. 2008....
Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarctionA Maisel
Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego 921161, USA
Circ Res 82:458-63. 1998..Additionally, this might be a useful model in which to study other immune-mediated cardiomyopathies...
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational StudyAlan S Maisel
Cardiology 111 A, San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
J Am Coll Cardiol 41:2010-7. 2003..This study examines B-type natriuretic peptide (BNP) levels in patients with systolic versus non-systolic dysfunction presenting with shortness of breath...
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trialAlan S Maisel
San Diego Veterans Affairs Medical Center, 3350 La Jolla Village Drive, University California, San Diego, CA, USA
Eur J Heart Fail 13:846-51. 2011..Renal dysfunction portends significant risk after discharge from acute heart failure (AHF). Thus, a sensitive marker of renal injury might also help to risk stratify HF patients...
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctionA S Maisel
Division of Cardiology, Veterans Affairs Medical Center and University of California, 3350 La Jolla Village Dr, San Diego, CA 92161, USA
Am Heart J 141:367-74. 2001..We hypothesized that BNP might therefore be useful as a screening tool before echocardiography in patients with suspected LV dysfunction...
B-type natriuretic peptide in the diagnosis and management of congestive heart failureA Maisel
Coronary Care Unit, Heart Failure Research Unit, Division of Cardiology, Department of Medicine, VA San Diego Health Care System, University of California, San Diego, California, USA
Cardiol Clin 19:557-71. 2001..Finally, the role of BNP in the outpatient cardiac or primary care clinic may be one of critical importance in titration of therapies and in assessment of the state of neurohormonal compensation of the patient...
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failureAlan S Maisel
University of California, San Diego, Veterans Affairs Medical Center, San Diego 92161, USA
N Engl J Med 347:161-7. 2002..B-type natriuretic peptide is released from the cardiac ventricles in response to increased wall tension...
Use of BNP levels in monitoring hospitalized heart failure patients with heart failureAlan S Maisel
Division of Cardiology, Department of Medicine, San Diego VA Healthcare System, San Diego, CA 92161, USA
Heart Fail Rev 8:339-44. 2003
Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel
VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
J Am Coll Cardiol 58:1057-67. 2011..The aim of this study was to determine the prognostic utility of midregion proadrenomedullin (MR-proADM) in all patients, cardiac and noncardiac, presenting with acute shortness of breath...
Nesiritide: a new therapy for the treatment of heart failureAlan S Maisel
San Diego VA Healthcare System, CA 92161, USA
Cardiovasc Toxicol 3:37-42. 2003..As a result, nesiritide is not arrhythmogenic. Nesiritide should be considered for patients presenting with acutely typical or useful decompensated heart failure, especially those with dyspnea at rest or with minimal activity...
B-type natriuretic peptide levels: diagnostic and therapeutic potentialA Maisel
Division of Cardiology and Department of Medicine, San Diego VA Healthcare System and University of California, San Diego, CA 92116, USA
Cardiovasc Toxicol 1:159-64. 2001..Measurement of BNP may also be an excellent screening tool for LV dysfunction. Key Words: Natriuretic peptides; neurohormonal; left-ventricular pressure;..
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot studyR Kazanegra
Division of Cardiology, Department of Medicine, Veteran's Affairs Medical Center, San Diego, California 92161, USA
J Card Fail 7:21-9. 2001..Although BNP levels will not obviate the need for invasive hemodynamic monitoring, it may be a useful adjunct in tailoring therapy to these patients...
B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspneaAlex Harrison
Division of Cardiology and General Internal Medicine, Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, CA, USA
Ann Emerg Med 39:131-8. 2002..CONCLUSION: In this study population, BNP levels measured in patients presenting with dyspnea to the ED are highly predictive of cardiac events over the next 6 months...
Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patientsVikas Bhalla
Division of Cardiology and the Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, San Diego, California 92161, USA
Am J Hypertens 18:73S-81S. 2005..73). CONCLUSIONS: In this high-risk hypertensive population, BNP, NT-BNP, and ICG were useful to identify the presence of LVD. The use of ICG with natriuretic peptide testing may improve the ability to detect LVD...
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational StudyLori B Daniels
University of California, San Diego, CA, USA
Am Heart J 151:999-1005. 2006..A lower cut-point (BNP > or = 54 pg/mL) should be used in severely obese patients to preserve sensitivity. A higher cut-point in lean patients (BNP > or = 170 pg/mL) could be used to increase specificity...
Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney diseaseWendy J Austin
Division of Cardiology and the Department of Medicine, Veteran Affairs Healthcare System San Diego and University of California, San Diego, USA
Am J Clin Pathol 126:506-12. 2006..99). Both peptides are useful prognostic tools for predicting mortality and cardiac hospitalization in renal patients...
Serial sampling of ST2 predicts 90-day mortality following destabilized heart failureSaskia Boisot
University of California at San Diego, Veteran Affairs San Diego Healthcare System, San Diego, CA 92161, USA
J Card Fail 14:732-8. 2008..To prospectively determine the prognostic utility of serial sampling of the interleukin-1 receptor family member, ST2, for predicting 90-day mortality in patients with heart failure (HF) admitted to a Veteran Affairs Medical Center...
Pro-B-type natriuretic peptide levels in acute decompensated heart failureStephen W Waldo
University of California at San Diego, Veterans Affairs San Diego Healthcare System, San Diego, California 92161, USA
J Am Coll Cardiol 51:1874-82. 2008..The present study sought to evaluate the clinical utility of pro-B-type natriuretic peptides (proBNP) in patients admitted with acute decompensated heart failure...
Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational studyCathrine W Knudsen
University of California, San Diego, Veteran's Affairs Medical Center, San Diego, CA, USA
Ann Emerg Med 45:573-80. 2005..CONCLUSION: Knowledge of these commonly obtained variables should aid clinicians in the interpretation of moderately elevated BNP results in patients presenting with acute dyspnea in the emergency department...
Natriuretic peptides as diagnostic test: lessons from the first 5 years of clinical applicationLori B Daniels
University of California San Diego, San Diego, CA, USA
Heart Fail Clin 2:299-309. 2006
Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac careNancy J Gardetto
San Diego VA Medical Center, University of California, San Diego, CA, USA
Crit Pathw Cardiol 7:153-72. 2008..Consequently, the development of clinical pathways has the potential to reduce the current variability in care, enhance guideline adherence, and improve outcomes for patients...
A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunctionDunya Atisha
Division of Cardiology and the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, Calif 92161, USA
Am Heart J 148:518-23. 2004....
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational StudyPeter A McCullough
University of California, San Diego Veteran s Affairs Medical Center, San Diego, CA, USA
Am J Kidney Dis 41:571-9. 2003..However, relationships between BNP, renal function, and heart failure as an emergency diagnosis are unknown...
Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical managementAlan S Maisel
Department of Medicine, Division of Cardiology, San Diego VA Healthcare System and University of California, San Diego, San Diego, California, USA
Rev Cardiovasc Med 4:S3-12. 2003..Thus, it is likely that future algorithms incorporating BNP levels and other clinical indicators will become available to guide critical-care physicians in making management decisions for their CHF patients...
Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgeryRyan Hutfless
University of California, San Diego, San Diego, California, USA
J Am Coll Cardiol 43:1873-9. 2004..Postoperatively, elevated peak BNP levels and elevated change to peak BNP levels were associated with prolonged hospital stay and mortality within one year...
Highlights of the year in JACC 2007Anthony N Demaria
Cardiology Division, University of California-San Diego, San Diego, California 92103-8411, USA
J Am Coll Cardiol 51:490-512. 2008
Natriuretic peptidesLori B Daniels
Division of Cardiology, University of California at San Diego, and Veteran s Affairs San Diego Healthcare System, San Diego, California 92037 1300, USA
J Am Coll Cardiol 50:2357-68. 2007..Knowing a patient's NP levels might thus assist with hemodynamic assessment and subsequent treatment titration. Monitoring NP levels in the outpatient setting might also improve patient care and outcomes...
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo StudyLori B Daniels
Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, California, USA
J Am Coll Cardiol 52:450-9. 2008..This study investigated the prognostic value of detectable cardiac troponin T (TnT) and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in a population of community-dwelling older adults...
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational StudyPeter A McCullough
University of California, Veteran s Affairs Medical Center, San Diego, USA
Circulation 106:416-22. 2002..We sought to determine the degree to which B-type natriuretic peptide (BNP) adds to clinical judgment in the diagnosis of congestive heart failure (CHF)...
Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational StudyAlan H B Wu
Department of Laboratory Medicine, University of California, San Francisco, San Francisco General Hospital, 1001 Potrero Ave, California 94110, USA
Am J Hematol 80:174-80. 2005..Among systolic HF patients, the presence of a low hemoglobin concentration is not a factor in the interpretation of BNP results...
Association of ST2 levels with cardiac structure and function and mortality in outpatientsLori B Daniels
Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA, USA
Am Heart J 160:721-8. 2010..The predictive value of ST2 levels in outpatients is unknown. We studied the clinical and echocardiographic correlates of ST2 levels and evaluated their prognostic use in outpatients referred for echocardiograms...
Highlights of the Year in JACC 2006Anthony N Demaria
Cardiology Division, University of California-San Diego, 92103-9000, USA
J Am Coll Cardiol 49:509-27. 2007
Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensationPam R Taub
University of California San Diego Medical Center, San Diego, CA 92103 8411, USA
Heart Fail Clin 5:169-75. 2009..Tools such as the natriuretic peptides are important adjuncts to the physical examination and chest radiographs and often obviate the need for invasive hemodynamic assessment...
Physical fitness attenuates leukocyte-endothelial adhesion in response to acute exercisePaul J Mills
Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA
J Appl Physiol 101:785-8. 2006..The findings provide evidence of how physical fitness might protect individuals from inflammatory responses to exercise...
Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptideMatthew McNairy
Division of Cardiology and the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, Calif 92161, USA
Am Heart J 143:406-11. 2002..Prior activity should not influence BNP levels in patients with congestive heart failure. Therefore, when a patient presents to clinic with a marked change in their BNP level, it may reflect a real change in their condition...
Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levelsLori B Daniels
Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA, USA
J Card Fail 16:93-8. 2010....
B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failureA Maisel
Division of Cardiology and Department of Medicine, San Diego VA Healthcare System, San Diego, California, USA
J Card Fail 7:183-93. 2001..Finally, the role of BNP in the outpatient cardiac or primary care clinic may be one of critical importance in titration of therapies as well as in assessing the state of neurohormonal compensation of the patient...
Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failureNiraj Parekh
Department of Cardiology, Veterans Affairs Hospital, University of California at San Diego, San Diego, CA, USA
Curr Opin Cardiol 24:155-60. 2009..Here we review current publications exploring the relationship between B-natriuretic peptide (BNP) and diastolic dysfunction...
Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failureRobert L Fitzgerald
Veterans Affair Medical Center, San Diego, California, USA
Am Heart J 150:471-7. 2005..05) lower than baseline. CONCLUSION: Nesiritide, in combination with standard therapy, significantly lowered the endogenous concentrations of natriuretic peptides during infusion and after dosing was completed...
B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure eventsLuis R Castellanos
Division of Cardiology, Department of Medicine Veteran s Affairs San Diego Healthcare System, La Jolla, CA 92161, USA
J Card Fail 15:41-7. 2009....
Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordingsGary S Mak
Cardiology Division, Department of Medicine, University of California, San Diego, Calif, USA
Am Heart J 148:895-902. 2004....
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitusMeenakshi A Bhalla
Division of Cardiology, Veteran's Affairs Medical Center, San Diego, California 92161, USA
J Am Coll Cardiol 44:1047-52. 2004..There was a marked decrease in survival in the patient group with BNP >120 pg/ml. CONCLUSIONS: B-type natriuretic peptide appears to be a reliable predictor of future cardiac and all-cause mortality in diabetic patients...
Use of biomarkers in evaluation of patients with heart failureLeo Slavin
Division of Cardiology, University of California, San Diego, Calif, USA
Contrib Nephrol 164:88-117. 2010..This review focuses on biomarkers resulting from hemodynamic stress, injury and inflammation, and their clinical relevance in modern practice...
Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testingAlan H B Wu
Department of Pathology and Laboratory Medicine, Hartford Hospital, 80 Seymour St, Hartford, CT 06102, USA
Eur J Heart Fail 6:309-12. 2004..Effective disease management requires an accurate diagnosis. B-type natriuretic peptide (BNP) is increased in patients with HF and is normal in PD patients without cardiac involvement...
B-type natriuretic peptides: a diagnostic breakthrough for cliniciansPeter A McCullough
Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
Rev Cardiovasc Med 4:72-80. 2003..This article reviews the literature concerning the use of these peptides in a variety of clinical scenarios...
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency departmentPeter A McCullough
William Beaumont Hospital, Royal Oak, MI 48073, USA
Acad Emerg Med 10:198-204. 2003..Heart failure, asthma, and chronic obstructive pulmonary disease (COPD) are syndromes where dyspnea and wheezing are overlapping signs, and hence, these syndromes are often difficult to differentiate...
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspneaPhilippe Gabriel Steg
Cardiology, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
Chest 128:21-9. 2005..Echocardiography and B-type natriuretic peptide (BNP) are diagnostic tests for congestive heart failure (CHF), but an emergency diagnosis can be difficult...
B-type natriuretic peptide in the emergency department: a valuable diagnostic aidAlan S Maisel
Acad Emerg Med 12:572-3; author reply 573-4. 2005
Relationship between obesity and B-type natriuretic peptide levelsJames McCord
Henry Ford Heart and Vascular Institute, Henry Ford Health System, Detroit, Mich, USA
Arch Intern Med 164:2247-52. 2004..When considering demographics, severity of disease, and renal function, BMI is not independently related to BNP levels in a small subgroup when detailed information about CHF severity is known...
Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter studyCynthia K Brenden
Hennepin County Medical Center, Minneapolis, MN, USA
Am Heart J 151:1006-11. 2006..CONCLUSIONS: In patients with established CHF, those with gray zone BNP levels have a better prognosis than those with non-gray zone levels despite being perceived by physicians as having New York Heart Association class III or IV CHF...
The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational StudyAlan H B Wu
Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut, USA
Diabetes Care 27:2398-404. 2004..We determined the effect of diabetes on B-type natriuretic peptide (BNP) concentrations in patients presenting to the emergency department with dyspnea...
B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary diseaseAlan S Maisel
Crit Care Med 35:301-3. 2007
Evidence for functional heterogeneity of circulating B-type natriuretic peptideFaquan Liang
Scios, Inc, Fremont, California 94555, USA
J Am Coll Cardiol 49:1071-8. 2007..These studies describe molecular forms of circulating B-type natriuretic peptide (BNP) as well as their biological activity...
Use of natriuretic peptides in pre-participation screening of college athletesLori B Daniels
Int J Cardiol 124:411-4. 2008....
Algorithms for assessing cardiovascular risk in womenLori B Daniels
JAMA 298:177; author reply 177-8. 2007
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) studyJames L Januzzi
Department of Medicine and Laboratory Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Am Coll Cardiol 50:607-13. 2007..The aim of this study was to examine the value of measurement of the interleukin-1 receptor family member ST2 in patients with dyspnea...
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approachPeter S Pang
Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Eur Heart J 29:816-24. 2008..This proposed tool requires detailed validation but has face validity for the uniform assessment of dyspnoea...
Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspneaCathrine W Knudsen
, Oslo, Norway
Am J Med 116:363-8. 2004..CONCLUSION: In patients presenting to the emergency department with acute dyspnea, BNP levels and chest radiographs provide complementary diagnostic information that may be useful in the early evaluation of heart failure...
Evolution of B-type natriuretic peptide in evaluation of intensive care unit shockVikas Bhalla
Crit Care Med 32:1787-9. 2004
Evolving use of B-type natriuretic peptide in clinical practiceAlex Harrison
Clin Chem 50:1714-5. 2004
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failureJames L Januzzi
Circulation 109:e325-6; author reply e325-6. 2004
B-type natriuretic peptide. A biomarker for all the right reasonsVikas Bhalla
Ital Heart J 5:417-20. 2004
Screening for asymptomatic left ventricular dysfunction using B-type natriuretic PeptideTheresa A McDonagh
Royal Brompton Hospital, London, UK
Congest Heart Fail 14:5-8. 2008....
